Moreover, LDLR (low-density lipoprotein receptor) was highly expressed in EGFR-mutated NSCLC cells, suggesting a role of EGFR signaling in upregulating LDLR expression through an AKT-mediated, SREBP1-dependent pathway [83]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.